Hormones 2016

Common therapies
Effect
No increased risk or
inconclusive research
Notes
Loss of bone density
Breast cancer
Cervical cancer
Ovarian cancer
Uterine cancer (Transhealth, 2015b).
Table 3.13 – The risks associated with masculinizing hormone therapy
Common therapies
Oestrogens
Option What is it? Advantages Disadvantages
Oral Oestrogen A pill you Less expensive Higher
(e.g. Estrace) swallow or
cardiovascular
dissolve under
risk for people
your tongue each
over 40, or
day
people with
other risk factors
Oestrogen Patch A patch you Lower
More expensive.
(e.g. Estradot, wear on your cardiovascular Some people
Estraderm) skin that gets risk for people have a skin
changed twice a over 40, or reaction to the
week
people with adhesive in the
other risk factors patch
Injectable Oestrogen
A substance you Lower
More expensive.
(e.g. estra-
inject every two cardiovascular Less widely
diol valerate) weeks
risk for people available. Some
over 40, or people find
people with injections to
other risk factors be painful.
Improper
injection can
be dangerous
(Transhealth,
2015a)
Name Safety & Source
Efficacy
Estradiol Valerate excellent synthetic (plant-based ?)
Ethinylestradiol Deprecated
fair synthetic
Version 2016.3576– – Document LATEXed – 1st May 2016
44
[git] • Branch: 1.5 @ 26b5e6d • Release: 1.5 (2016-05-01)